J. Goldman & CO LP Acer Therapeutics Inc. Transaction History

J. Goldman & CO LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.47 - $4.39 $889,200 - $1.58 Million	-360,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.34 - $2.99 $842,400 - $1.08 Million	360,000 New	360,000 $943,000
Q1 2020 May 15, 2020	SELL	$1.18 - $5.86 $86,741 - $430,768	-73,510 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.85 - $4.2 $225,976 - $333,018	-79,290 Reduced 51.89%	73,510 $295,000
Q3 2019 Nov 14, 2019	BUY	$1.95 - $3.93 $102,958 - $207,500	52,799 Added 52.8%	152,800 $487,000
Q2 2019 Aug 14, 2019	BUY	$3.45 - $26.86 $345,003 - $2.69 Million	100,001 New	100,001 $390,000
Q3 2018 Nov 14, 2018	SELL	$18.0 - $32.83 $732,312 - $1.34 Million	-40,684 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$17.71 - $21.6 $876,963 - $1.07 Million	-49,518 Reduced 54.9%	40,684 $879,000
Q1 2018 May 15, 2018	SELL	$14.81 - $20.22 $263,588 - $359,875	-17,798 Reduced 16.48%	90,202 $1.74 Million
Q4 2017 Feb 14, 2018	BUY	$11.81 - $19.35 $1.28 Million - $2.09 Million	108,000	108,000 $1.5 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.